Latest Breaking News On - With myopiax - Page 1 : comparemela.com

Safe and Tolerable: MyopiaX-1 proof-of-concept clinical trial (NCT04967287) supports MyopiaX's excellent safety and tolerability profile with no untoward safety events. Novel Approach: Dopavision's

Novartis pharmaDopavision gmbIan flitcroftMark wuttkeAbabax healthBoehringer ingelheim venture fundGerman federal ministry of educationBusiness wireCoordinating investigatorWith myopiaxSeventure partnersGerman federal ministryExecutive officerIhr portfolio